Kumar S. .2022 .Hormonal and targeted treatments in breast cancer.". In Breast Cancer: Comprehensive Management, : 443-463.
Ghanavati M. .1806 .Tamoxifen use and risk of endometrial cancer in breast cancer patients: A systematic review and dose-response meta‐analysis. ” Cancer Reports, 6(4) : e1806.
Remmel H.L. .2024 ."Comparative analysis of Endoxifen, Tamoxifen and Fulvestrant: A Bioinformatics Approach to Uncover Mechanisms of Action in Breast Cancer. " bioRxiv, : 2024-10.
Falato C. .2022 .Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and her2- negative metastatic breast cancer. ” Cancer Treatment Reviews, 102496 : 102496.
Smolarz B. .2022 .Breast cancer-epidemiology, classification, pathogenesis and treatment (review of literature). ” Cancers, 14(10) : 2569-0.
Tsai Y.C. .2024 ."Investigating radiation therapy treatments with cell cycle and DNA repair inhibitors in triple-negative breast cancer." Department of Medicine. McGill University, : .
Liao Y. .2023 .Ethyl acetate extract of antenoron filiforme inhibits the proliferation of triple negative breast cancer cells via suppressing skp2/p21 signaling axis. ” Phytomedicine, 154856 : 154856-0.
Shaikh M.A.J. .2024 .Non-coding RNAs: Key regulators of CDK and Wnt/β-catenin signaling in cancer. ” Pathology - Research and Practice, 155659 : 155659-0.
Aung T.M. .2024 .Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis. ” PLOS ONE, 0303337(5) : e0303337-0.
Sun J. .2024 .Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (review. ” International Journal of Oncology, 64(4) : 44-0.
Khallouki F.,April 2023 . .An update on tamoxifen and the chemopreventive potential of vitamin e in breast cancer management. ” Journal of Personalized Medicine, 13(5) : 754-0.
Mir Manzoor,Ahmad Shazia,Sofi M. Sultan,Khan M. Sultan .2023 ."CDk Inhibitor for Treatment of Breast Cancer." In: Therapeutic Potential of Cell Cycle Kinases in Breast Cancer. , : 313-333.
Wiecken W,M. W .2024 .The immune checkpoint lag-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma. ” OncoImmunology, 2430066(1) : 2430066-0.
Vitale S.G. .2024 .Risk of endometrial malignancy in women treated for breast cancer: The BLUSH prediction model - evidence from a comprehensive multicentric retrospective cohort study. ” Climacteric, 2376189(5) : 482-488.
Faleh S. .2023 .Predictors of nodal metastases in early stage her2+ breast cancer: Deciding on treatment approach with neoadjuvant chemotherapy vs. upfront surgery. European Journal of Surgical Oncology, 03(8) : 1411-1416.
Chakravarti N.,April 2024 . .XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways. Scientific Reports, 14(1) : 9305-0.
Morgan J. .2023 .Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: A mixed methods study of patient and partner outcomes. The Annals of The Royal College of Surgeons of England, 0042(1) : 78-91.
Elfoly M. .2024 .Pd-l1 intrinsically promotes the proliferation of breast cancer cells through the skp2-p27/p21 axis. Cancer Cell International, 24(1) : 161-0.
Yue Y. .2021 .N6-methyladenosine-mediated downregulation of mir-374c-5p promotes cadmium-induced cell proliferation and metastasis by targeting grm3 in breast cancer cells. ” Ecotoxicology and Environmental Safety, 113085 : 113085-0.
Choi S.,November S. .2023 .MicroRNA-606 inhibits the growth and metastasis of triple-negative breast cancer by targeting Stanniocalcin 1. , 8661(1) : .
Nasri E. .2024 .Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.” The Cancer Journal. , 30(3) : 133-139.
Koh Y.W.,November 2024 . .Senescence cell signature associated with poor prognosis, epithelial-mesenchymal transition, solid histology and spread through air spaces in lung adenocarcinoma. GeroScience, 47(2) : 2423-2438.
Huang Y. . .Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer. ” Breast Cancer, 31(5) : 917-925.
Gowdini E.,November 2022 . .DOK7 CpG hypermethylation in blood leukocytes as an epigenetic biomarker for acquired tamoxifen resistant in breast cancer. ” Journal of Human Genetics, 68(1) : 33-38.
Liang X.,April 2022 . .DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer. ” Molecular Biology Reports, 49(5) : 3939-3947.
Tian Y. .2023 .DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2/M phase arrest mediated by DNA damage-driven upregulation of p21.” Biochemical Pharmacology. , 115518 : 115518-0.
Nasir A. . .p21 Protein Outperforms Clinico-pathological Criteria in Predicting Liver Metastases in Pancreatic Endocrine Tumors. ” Cancer Genomics - Proteomics, 20(2023) : 522-530.
Leelo A.K.,Leelo H.A.K. .2019 .Immunohistochemical expression of TGF-β1 and Ki-67 in a paraffin-embedded section of breast cancer tissue. Indian Journal of Forensic Medicine & Toxicology, 00453(2019) : 0973-9130.
Rajendran S. .2021 .p21 activated kinase-1 and tamoxifen - A deadly nexus impacting breast cancer outcomes. ” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 188668(1) : 188668-0.
White-Gilbertson S.,April 2024 .2024 .Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization. ” Journal of Biological Chemistry, 107136(4) : 107136-0.
Nakao T. . .Prognostic impact of the combination of p16ink4a, p21 and immunoscore in rectal cancer. International Journal of Clinical Oncology, 29(8) : 1152-1160.
April 2024 . .Low-level expression of p-S6 is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma. International Journal of Molecular Sciences, 25(8) : 4304-0.
Wang Y. .2021 .Improved breast cancer histological grading using deep learning. ” Annals of Oncology, 09(1) : 89-98.
Fei ,Yang ,J. Clin. Pathol. June .2024 .Clinicopathological significance and prognostic analysis of p21 and EGFR in colorectal cancer: A retrospective analysis on 12 319 cases. , : .
Lee D.H.,November 2023 . .CDK4/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents. ” Molecular Oncology, 18(1) : 13541-232.
Melo M.L. .2023 .N-acylhydrazone derivative modulates cell cycle regulators promoting mitosis arrest and apoptosis in estrogen positive mcf-7 breast cancer cells. ” Toxicology in Vitro, 105686 : 105686-0.
Margulies B.S. . .Reshaping the landscape of locoregional treatments for breast cancer liver metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in balb/c mice inoculated with 4t1 triple negative breast cancer cells in the liver. ” PLOS One, 0323621(6) : e0323621-0.
Liu R. .2023 .Stnm1 in human cancers: Role, function and potential therapy sensitizer. ” Cellular Signalling, 110775 : 110775-0.